Trojan Q10: Meet the game-changer in skin mitochondria therapy

Trojan Q10 changes the game of anti-aging, offering a 360º activity. Based on the cutting-edge Trojan Technology, recently developed at Infinitec, Trojan Q10 is able to surgically and effectively deliver Coenzyme Q10 (Q10) to the mitochondria of fibroblasts. In fact, Trojan Technology displays a dual-mode, extremely precise targeting ability: first targets fibroblast receptors, and once internalized into their cytosol, it targets mitochondria. Then, Q10 is released into the mitochondria. By the effective delivery of Q10 in correspondence of the mitochondria, Trojan Q10 unlocks unexploited features of Q10 in conventional treatments; Q10 can now participate to the mitochondria respiration, i.e. energy production, and it can neutralize mROS. Only by mastering these two actions of Q10, a Q10-based treatment can achieve unexpected anti-wrinkles effect in a short time and at a very low dose of Q10. Trojan Q10 speeds up wrinkles-related cellular processes, such as ECM proteins synthesis, fibroblasts turnover, etc as well as it minimizes mROS damage, leading to an increase in skin firmness and elasticity. Free Q10 cannot achieve these results because it is consumed by radicals before reaching the mitochondria. Trojan Q10 corrects the multiple signs of aging; it combats the decline of cell energy by restoring optimal mitochondrial activity, neutralizes reactive oxygen species (ROS) and increases ECM proteins synthesis. The skin looks rejuvenated, with increased elasticity and firmness.